Kim Janda - 30 Aug 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Issuer symbol
SRNEQ
Transactions as of
30 Aug 2021
Transactions value $
$0
Form type
4
Filing time
30 Aug 2021, 20:13:03 UTC
Next filing
14 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock option (right to buy) Award $0 +250,000 $0 250,000 30 Aug 2021 Common Stock 250,000 $8.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.